Genitourinary syndrome of menopause (GSM): recommendations from the Fifth International Consultation on Sexual Medicine (ICSM 2024)
GSM is a relatively new disorder with an expanded definition to further the older long-recognized condition of vulvovaginal atrophy (VVA) in postmenopausal women to include urinary symptoms and anchor the disorder to menopause and the hypoestrogenic state. This new disorder has provided renewed incentives to formalize a significant amount of multidisciplinary research in the last decade. However, many areas ranging from epidemiology to tailored effective and safe treatment options in clinical practice still require in-depth additional investigations.
Authors
- Wendy Wolfman (ORCID: https://orcid.org/0000-0001-8996-7303)
- Peter A. Chedraui (ORCID: https://orcid.org/0000-0002-1556-3979)
- Amanda Clark (ORCID: https://orcid.org/0000-0001-5173-8847)
- Santiago Palacios (ORCID: https://orcid.org/0000-0003-2229-1200)
- Anne Gompel (ORCID: https://orcid.org/0000-0001-9614-6968)
- James A. Simon (ORCID: https://orcid.org/0000-0002-6968-5250)
- Rossella E. Nappi (ORCID: https://orcid.org/0000-0002-5216-9882)
- Shaikh Zinnat Ara Nasreen
Institutions
- Mount Sinai Hospital (CA)
- George Washington University (US)
- Université Paris Cité (FR)
- University of Pavia (IT)
- Foundation Center (US)
- Universidad Espíritu Santo (EC)
- Hôpital Cochin (FR)
- Women Medical College (PK)
- Maternité Port Royal (FR)
- Instituto Palacios (ES)
- Kaiser Permanente Center for Health Research (US)
- Institute for Female Pelvic Medicine and Reconstructive Surgery (US)
Publication Details
- Journal
- Sexual Medicine Reviews
- Published
- 2025-08-27
- DOI
- https://doi.org/10.1093/sxmrev/qeaf055
- Citations
- 3
- Primary Topic
- Pelvic floor disorders treatments
- Type
- article
- Field-Weighted Citation Impact
- 5.00